Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide. Elpiscience has a robust pipeline of globally innovative cancer immunotherapies covering a wide range of oncology targets. Through internal R&D expertise and partnerships with global biopharmaceutical companies, Elpiscience endeavors to advance at least one innovative program into clinic each year.
Innovate transformative medicines that improve cancer patients' lives worldwide.
Make everything possible!
Let you win!
Help you achieve your career!
To discover and develop novel high-quality cancer therapeutics efficiently.